nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Itraconazole—CYP2E1—lung cancer	0.00813	0.19	CrCbGaD
Terconazole—Posaconazole—ABCB1—lung cancer	0.00811	0.19	CrCbGaD
Terconazole—Itraconazole—CYP1A1—lung cancer	0.00802	0.188	CrCbGaD
Terconazole—Ketoconazole—CYP2A6—lung cancer	0.00686	0.16	CrCbGaD
Terconazole—Ketoconazole—CYP1A1—lung cancer	0.0048	0.112	CrCbGaD
Terconazole—Vomiting—Pemetrexed—lung cancer	0.0045	0.0047	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.00448	0.00468	CcSEcCtD
Terconazole—Vomiting—Gefitinib—lung cancer	0.00447	0.00467	CcSEcCtD
Terconazole—Rash—Pemetrexed—lung cancer	0.00446	0.00466	CcSEcCtD
Terconazole—Dermatitis—Pemetrexed—lung cancer	0.00446	0.00466	CcSEcCtD
Terconazole—Rash—Gefitinib—lung cancer	0.00444	0.00463	CcSEcCtD
Terconazole—Arthralgia—Topotecan—lung cancer	0.00443	0.00463	CcSEcCtD
Terconazole—Myalgia—Topotecan—lung cancer	0.00443	0.00463	CcSEcCtD
Terconazole—Dermatitis—Gefitinib—lung cancer	0.00443	0.00463	CcSEcCtD
Terconazole—Myalgia—Erlotinib—lung cancer	0.00439	0.00458	CcSEcCtD
Terconazole—Arthralgia—Erlotinib—lung cancer	0.00439	0.00458	CcSEcCtD
Terconazole—Discomfort—Topotecan—lung cancer	0.00438	0.00458	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—lung cancer	0.00431	0.00451	CcSEcCtD
Terconazole—Itraconazole—ABCB1—lung cancer	0.00426	0.0997	CrCbGaD
Terconazole—Anaphylactic shock—Topotecan—lung cancer	0.00425	0.00444	CcSEcCtD
Terconazole—Hypersensitivity—Teniposide—lung cancer	0.00423	0.00441	CcSEcCtD
Terconazole—Nausea—Pemetrexed—lung cancer	0.00421	0.00439	CcSEcCtD
Terconazole—Nausea—Gefitinib—lung cancer	0.00418	0.00436	CcSEcCtD
Terconazole—Ill-defined disorder—Vinorelbine—lung cancer	0.00413	0.00432	CcSEcCtD
Terconazole—Asthenia—Teniposide—lung cancer	0.00411	0.0043	CcSEcCtD
Terconazole—Pruritus—Teniposide—lung cancer	0.00406	0.00424	CcSEcCtD
Terconazole—Malaise—Vinorelbine—lung cancer	0.00402	0.0042	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Topotecan—lung cancer	0.00387	0.00405	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00383	0.004	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.0038	0.00397	CcSEcCtD
Terconazole—Myalgia—Vinorelbine—lung cancer	0.00379	0.00396	CcSEcCtD
Terconazole—Arthralgia—Vinorelbine—lung cancer	0.00379	0.00396	CcSEcCtD
Terconazole—Chills—Irinotecan—lung cancer	0.00379	0.00396	CcSEcCtD
Terconazole—Discomfort—Vinorelbine—lung cancer	0.00375	0.00391	CcSEcCtD
Terconazole—Pain—Vinblastine—lung cancer	0.00374	0.00391	CcSEcCtD
Terconazole—Chills—Gemcitabine—lung cancer	0.00369	0.00385	CcSEcCtD
Terconazole—Vomiting—Teniposide—lung cancer	0.00365	0.00381	CcSEcCtD
Terconazole—Anaphylactic shock—Vinorelbine—lung cancer	0.00364	0.0038	CcSEcCtD
Terconazole—Pain—Topotecan—lung cancer	0.00363	0.0038	CcSEcCtD
Terconazole—Rash—Teniposide—lung cancer	0.00362	0.00378	CcSEcCtD
Terconazole—Dermatitis—Teniposide—lung cancer	0.00361	0.00377	CcSEcCtD
Terconazole—Feeling abnormal—Vinblastine—lung cancer	0.00361	0.00377	CcSEcCtD
Terconazole—Pain—Erlotinib—lung cancer	0.0036	0.00376	CcSEcCtD
Terconazole—Headache—Teniposide—lung cancer	0.00359	0.00375	CcSEcCtD
Terconazole—Bronchospasm—Docetaxel—lung cancer	0.00359	0.00375	CcSEcCtD
Terconazole—Gastrointestinal pain—Vinblastine—lung cancer	0.00358	0.00374	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—lung cancer	0.00352	0.00368	CcSEcCtD
Terconazole—Feeling abnormal—Topotecan—lung cancer	0.0035	0.00366	CcSEcCtD
Terconazole—Gastrointestinal pain—Topotecan—lung cancer	0.00348	0.00363	CcSEcCtD
Terconazole—Abdominal pain—Vinblastine—lung cancer	0.00346	0.00361	CcSEcCtD
Terconazole—Gastrointestinal pain—Erlotinib—lung cancer	0.00344	0.00359	CcSEcCtD
Terconazole—Ill-defined disorder—Irinotecan—lung cancer	0.00341	0.00356	CcSEcCtD
Terconazole—Nausea—Teniposide—lung cancer	0.00341	0.00356	CcSEcCtD
Terconazole—Urticaria—Topotecan—lung cancer	0.00338	0.00353	CcSEcCtD
Terconazole—Abdominal pain—Topotecan—lung cancer	0.00336	0.00351	CcSEcCtD
Terconazole—Body temperature increased—Topotecan—lung cancer	0.00336	0.00351	CcSEcCtD
Terconazole—Body temperature increased—Erlotinib—lung cancer	0.00332	0.00347	CcSEcCtD
Terconazole—Abdominal pain—Erlotinib—lung cancer	0.00332	0.00347	CcSEcCtD
Terconazole—Ill-defined disorder—Gemcitabine—lung cancer	0.00332	0.00347	CcSEcCtD
Terconazole—Malaise—Irinotecan—lung cancer	0.00331	0.00346	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00331	0.00346	CcSEcCtD
Terconazole—Malaise—Gemcitabine—lung cancer	0.00323	0.00337	CcSEcCtD
Terconazole—Hypersensitivity—Vinblastine—lung cancer	0.00322	0.00337	CcSEcCtD
Terconazole—Chills—Etoposide—lung cancer	0.00315	0.00329	CcSEcCtD
Terconazole—Asthenia—Vinblastine—lung cancer	0.00314	0.00328	CcSEcCtD
Terconazole—Hypersensitivity—Topotecan—lung cancer	0.00313	0.00327	CcSEcCtD
Terconazole—Pain—Vinorelbine—lung cancer	0.00311	0.00325	CcSEcCtD
Terconazole—Ill-defined disorder—Cisplatin—lung cancer	0.0031	0.00323	CcSEcCtD
Terconazole—Discomfort—Irinotecan—lung cancer	0.00309	0.00323	CcSEcCtD
Terconazole—Chills—Paclitaxel—lung cancer	0.00309	0.00323	CcSEcCtD
Terconazole—Asthenia—Topotecan—lung cancer	0.00305	0.00319	CcSEcCtD
Terconazole—Arthralgia—Gemcitabine—lung cancer	0.00305	0.00318	CcSEcCtD
Terconazole—Myalgia—Gemcitabine—lung cancer	0.00305	0.00318	CcSEcCtD
Terconazole—Asthenia—Erlotinib—lung cancer	0.00302	0.00315	CcSEcCtD
Terconazole—Discomfort—Gemcitabine—lung cancer	0.00301	0.00314	CcSEcCtD
Terconazole—Malaise—Cisplatin—lung cancer	0.00301	0.00314	CcSEcCtD
Terconazole—Pruritus—Topotecan—lung cancer	0.00301	0.00314	CcSEcCtD
Terconazole—Anaphylactic shock—Irinotecan—lung cancer	0.003	0.00313	CcSEcCtD
Terconazole—Feeling abnormal—Vinorelbine—lung cancer	0.003	0.00313	CcSEcCtD
Terconazole—Pruritus—Erlotinib—lung cancer	0.00298	0.00311	CcSEcCtD
Terconazole—Gastrointestinal pain—Vinorelbine—lung cancer	0.00297	0.00311	CcSEcCtD
Terconazole—Anaphylactic shock—Gemcitabine—lung cancer	0.00292	0.00305	CcSEcCtD
Terconazole—Dizziness—Vinblastine—lung cancer	0.00289	0.00302	CcSEcCtD
Terconazole—Urticaria—Vinorelbine—lung cancer	0.00289	0.00302	CcSEcCtD
Terconazole—Body temperature increased—Vinorelbine—lung cancer	0.00287	0.003	CcSEcCtD
Terconazole—Abdominal pain—Vinorelbine—lung cancer	0.00287	0.003	CcSEcCtD
Terconazole—Myalgia—Cisplatin—lung cancer	0.00284	0.00297	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—lung cancer	0.00284	0.00296	CcSEcCtD
Terconazole—Dizziness—Topotecan—lung cancer	0.00281	0.00294	CcSEcCtD
Terconazole—Discomfort—Cisplatin—lung cancer	0.00281	0.00293	CcSEcCtD
Terconazole—Vomiting—Vinblastine—lung cancer	0.00278	0.00291	CcSEcCtD
Terconazole—Dizziness—Erlotinib—lung cancer	0.00278	0.00291	CcSEcCtD
Terconazole—Ill-defined disorder—Paclitaxel—lung cancer	0.00278	0.0029	CcSEcCtD
Terconazole—Malaise—Etoposide—lung cancer	0.00276	0.00288	CcSEcCtD
Terconazole—Headache—Vinblastine—lung cancer	0.00274	0.00286	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00274	0.00286	CcSEcCtD
Terconazole—Anaphylactic shock—Cisplatin—lung cancer	0.00272	0.00284	CcSEcCtD
Terconazole—Vomiting—Topotecan—lung cancer	0.0027	0.00282	CcSEcCtD
Terconazole—Malaise—Paclitaxel—lung cancer	0.0027	0.00282	CcSEcCtD
Terconazole—Rash—Topotecan—lung cancer	0.00268	0.0028	CcSEcCtD
Terconazole—Hypersensitivity—Vinorelbine—lung cancer	0.00268	0.0028	CcSEcCtD
Terconazole—Dermatitis—Topotecan—lung cancer	0.00268	0.0028	CcSEcCtD
Terconazole—Vomiting—Erlotinib—lung cancer	0.00267	0.00279	CcSEcCtD
Terconazole—Headache—Topotecan—lung cancer	0.00266	0.00278	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00266	0.00278	CcSEcCtD
Terconazole—Rash—Erlotinib—lung cancer	0.00265	0.00277	CcSEcCtD
Terconazole—Dermatitis—Erlotinib—lung cancer	0.00265	0.00277	CcSEcCtD
Terconazole—Headache—Erlotinib—lung cancer	0.00263	0.00275	CcSEcCtD
Terconazole—Chills—Docetaxel—lung cancer	0.00262	0.00273	CcSEcCtD
Terconazole—Asthenia—Vinorelbine—lung cancer	0.00261	0.00273	CcSEcCtD
Terconazole—Nausea—Vinblastine—lung cancer	0.0026	0.00271	CcSEcCtD
Terconazole—Pruritus—Vinorelbine—lung cancer	0.00257	0.00269	CcSEcCtD
Terconazole—Discomfort—Etoposide—lung cancer	0.00257	0.00269	CcSEcCtD
Terconazole—Pain—Irinotecan—lung cancer	0.00256	0.00268	CcSEcCtD
Terconazole—Ketoconazole—ABCB1—lung cancer	0.00255	0.0597	CrCbGaD
Terconazole—Arthralgia—Paclitaxel—lung cancer	0.00255	0.00267	CcSEcCtD
Terconazole—Myalgia—Paclitaxel—lung cancer	0.00255	0.00267	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—lung cancer	0.00254	0.00265	CcSEcCtD
Terconazole—Nausea—Topotecan—lung cancer	0.00252	0.00264	CcSEcCtD
Terconazole—Discomfort—Paclitaxel—lung cancer	0.00252	0.00263	CcSEcCtD
Terconazole—Pain—Gemcitabine—lung cancer	0.0025	0.00261	CcSEcCtD
Terconazole—Nausea—Erlotinib—lung cancer	0.0025	0.00261	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—lung cancer	0.00249	0.00261	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00248	0.00259	CcSEcCtD
Terconazole—Feeling abnormal—Irinotecan—lung cancer	0.00247	0.00258	CcSEcCtD
Terconazole—Gastrointestinal pain—Irinotecan—lung cancer	0.00245	0.00256	CcSEcCtD
Terconazole—Anaphylactic shock—Paclitaxel—lung cancer	0.00245	0.00255	CcSEcCtD
Terconazole—Feeling abnormal—Gemcitabine—lung cancer	0.00241	0.00251	CcSEcCtD
Terconazole—Dizziness—Vinorelbine—lung cancer	0.0024	0.00251	CcSEcCtD
Terconazole—Abdominal pain—Irinotecan—lung cancer	0.00237	0.00248	CcSEcCtD
Terconazole—Body temperature increased—Irinotecan—lung cancer	0.00237	0.00248	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00237	0.00248	CcSEcCtD
Terconazole—Pain—Cisplatin—lung cancer	0.00233	0.00243	CcSEcCtD
Terconazole—Vomiting—Vinorelbine—lung cancer	0.00231	0.00242	CcSEcCtD
Terconazole—Body temperature increased—Gemcitabine—lung cancer	0.00231	0.00241	CcSEcCtD
Terconazole—Rash—Vinorelbine—lung cancer	0.00229	0.00239	CcSEcCtD
Terconazole—Dermatitis—Vinorelbine—lung cancer	0.00229	0.00239	CcSEcCtD
Terconazole—Headache—Vinorelbine—lung cancer	0.00228	0.00238	CcSEcCtD
Terconazole—Feeling abnormal—Cisplatin—lung cancer	0.00224	0.00234	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00223	0.00233	CcSEcCtD
Terconazole—Hypersensitivity—Irinotecan—lung cancer	0.00221	0.00231	CcSEcCtD
Terconazole—Myalgia—Docetaxel—lung cancer	0.00216	0.00226	CcSEcCtD
Terconazole—Arthralgia—Docetaxel—lung cancer	0.00216	0.00226	CcSEcCtD
Terconazole—Nausea—Vinorelbine—lung cancer	0.00216	0.00226	CcSEcCtD
Terconazole—Body temperature increased—Cisplatin—lung cancer	0.00215	0.00225	CcSEcCtD
Terconazole—Asthenia—Irinotecan—lung cancer	0.00215	0.00225	CcSEcCtD
Terconazole—Pain—Etoposide—lung cancer	0.00213	0.00223	CcSEcCtD
Terconazole—Asthenia—Gemcitabine—lung cancer	0.0021	0.00219	CcSEcCtD
Terconazole—Pain—Paclitaxel—lung cancer	0.00209	0.00218	CcSEcCtD
Terconazole—Anaphylactic shock—Docetaxel—lung cancer	0.00207	0.00217	CcSEcCtD
Terconazole—Pruritus—Gemcitabine—lung cancer	0.00207	0.00216	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—lung cancer	0.00206	0.00215	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—lung cancer	0.00204	0.00213	CcSEcCtD
Terconazole—Feeling abnormal—Paclitaxel—lung cancer	0.00202	0.00211	CcSEcCtD
Terconazole—Hypersensitivity—Cisplatin—lung cancer	0.00201	0.0021	CcSEcCtD
Terconazole—Gastrointestinal pain—Paclitaxel—lung cancer	0.002	0.00209	CcSEcCtD
Terconazole—Dizziness—Irinotecan—lung cancer	0.00198	0.00207	CcSEcCtD
Terconazole—Urticaria—Etoposide—lung cancer	0.00198	0.00207	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—lung cancer	0.00197	0.00206	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—lung cancer	0.00197	0.00206	CcSEcCtD
Terconazole—Asthenia—Cisplatin—lung cancer	0.00195	0.00204	CcSEcCtD
Terconazole—Urticaria—Paclitaxel—lung cancer	0.00194	0.00203	CcSEcCtD
Terconazole—Abdominal pain—Paclitaxel—lung cancer	0.00193	0.00202	CcSEcCtD
Terconazole—Body temperature increased—Paclitaxel—lung cancer	0.00193	0.00202	CcSEcCtD
Terconazole—Vomiting—Irinotecan—lung cancer	0.00191	0.00199	CcSEcCtD
Terconazole—Rash—Irinotecan—lung cancer	0.00189	0.00198	CcSEcCtD
Terconazole—Dermatitis—Irinotecan—lung cancer	0.00189	0.00197	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00189	0.00197	CcSEcCtD
Terconazole—Chills—Methotrexate—lung cancer	0.00189	0.00197	CcSEcCtD
Terconazole—Headache—Irinotecan—lung cancer	0.00188	0.00196	CcSEcCtD
Terconazole—Vomiting—Gemcitabine—lung cancer	0.00186	0.00194	CcSEcCtD
Terconazole—Rash—Gemcitabine—lung cancer	0.00184	0.00192	CcSEcCtD
Terconazole—Dermatitis—Gemcitabine—lung cancer	0.00184	0.00192	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—lung cancer	0.00184	0.00192	CcSEcCtD
Terconazole—Headache—Gemcitabine—lung cancer	0.00183	0.00191	CcSEcCtD
Terconazole—Hypersensitivity—Paclitaxel—lung cancer	0.0018	0.00188	CcSEcCtD
Terconazole—Asthenia—Etoposide—lung cancer	0.00179	0.00187	CcSEcCtD
Terconazole—Nausea—Irinotecan—lung cancer	0.00178	0.00186	CcSEcCtD
Terconazole—Pain—Docetaxel—lung cancer	0.00177	0.00185	CcSEcCtD
Terconazole—Pruritus—Etoposide—lung cancer	0.00176	0.00184	CcSEcCtD
Terconazole—Asthenia—Paclitaxel—lung cancer	0.00175	0.00183	CcSEcCtD
Terconazole—Nausea—Gemcitabine—lung cancer	0.00174	0.00181	CcSEcCtD
Terconazole—Vomiting—Cisplatin—lung cancer	0.00173	0.00181	CcSEcCtD
Terconazole—Pruritus—Paclitaxel—lung cancer	0.00173	0.00181	CcSEcCtD
Terconazole—Rash—Cisplatin—lung cancer	0.00172	0.00179	CcSEcCtD
Terconazole—Dermatitis—Cisplatin—lung cancer	0.00172	0.00179	CcSEcCtD
Terconazole—Feeling abnormal—Docetaxel—lung cancer	0.00171	0.00178	CcSEcCtD
Terconazole—Ill-defined disorder—Methotrexate—lung cancer	0.0017	0.00177	CcSEcCtD
Terconazole—Gastrointestinal pain—Docetaxel—lung cancer	0.0017	0.00177	CcSEcCtD
Terconazole—Malaise—Methotrexate—lung cancer	0.00165	0.00172	CcSEcCtD
Terconazole—Dizziness—Etoposide—lung cancer	0.00165	0.00172	CcSEcCtD
Terconazole—Abdominal pain—Docetaxel—lung cancer	0.00164	0.00171	CcSEcCtD
Terconazole—Body temperature increased—Docetaxel—lung cancer	0.00164	0.00171	CcSEcCtD
Terconazole—Chills—Doxorubicin—lung cancer	0.00163	0.00171	CcSEcCtD
Terconazole—Dizziness—Paclitaxel—lung cancer	0.00162	0.00169	CcSEcCtD
Terconazole—Nausea—Cisplatin—lung cancer	0.00162	0.00169	CcSEcCtD
Terconazole—Vomiting—Etoposide—lung cancer	0.00159	0.00166	CcSEcCtD
Terconazole—Rash—Etoposide—lung cancer	0.00157	0.00164	CcSEcCtD
Terconazole—Dermatitis—Etoposide—lung cancer	0.00157	0.00164	CcSEcCtD
Terconazole—Headache—Etoposide—lung cancer	0.00156	0.00163	CcSEcCtD
Terconazole—Arthralgia—Methotrexate—lung cancer	0.00156	0.00163	CcSEcCtD
Terconazole—Myalgia—Methotrexate—lung cancer	0.00156	0.00163	CcSEcCtD
Terconazole—Vomiting—Paclitaxel—lung cancer	0.00155	0.00162	CcSEcCtD
Terconazole—Rash—Paclitaxel—lung cancer	0.00154	0.00161	CcSEcCtD
Terconazole—Dermatitis—Paclitaxel—lung cancer	0.00154	0.00161	CcSEcCtD
Terconazole—Discomfort—Methotrexate—lung cancer	0.00154	0.00161	CcSEcCtD
Terconazole—Headache—Paclitaxel—lung cancer	0.00153	0.0016	CcSEcCtD
Terconazole—Hypersensitivity—Docetaxel—lung cancer	0.00153	0.0016	CcSEcCtD
Terconazole—Anaphylactic shock—Methotrexate—lung cancer	0.00149	0.00156	CcSEcCtD
Terconazole—Asthenia—Docetaxel—lung cancer	0.00149	0.00155	CcSEcCtD
Terconazole—Nausea—Etoposide—lung cancer	0.00148	0.00155	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—lung cancer	0.00147	0.00154	CcSEcCtD
Terconazole—Pruritus—Docetaxel—lung cancer	0.00147	0.00153	CcSEcCtD
Terconazole—Nausea—Paclitaxel—lung cancer	0.00145	0.00152	CcSEcCtD
Terconazole—Malaise—Doxorubicin—lung cancer	0.00143	0.00149	CcSEcCtD
Terconazole—Dizziness—Docetaxel—lung cancer	0.00137	0.00143	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00136	0.00142	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—lung cancer	0.00135	0.00141	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—lung cancer	0.00135	0.00141	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—lung cancer	0.00133	0.00139	CcSEcCtD
Terconazole—Vomiting—Docetaxel—lung cancer	0.00132	0.00138	CcSEcCtD
Terconazole—Rash—Docetaxel—lung cancer	0.00131	0.00137	CcSEcCtD
Terconazole—Dermatitis—Docetaxel—lung cancer	0.00131	0.00136	CcSEcCtD
Terconazole—Headache—Docetaxel—lung cancer	0.0013	0.00136	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—lung cancer	0.00129	0.00135	CcSEcCtD
Terconazole—Pain—Methotrexate—lung cancer	0.00128	0.00133	CcSEcCtD
Terconazole—Nausea—Docetaxel—lung cancer	0.00123	0.00129	CcSEcCtD
Terconazole—Feeling abnormal—Methotrexate—lung cancer	0.00123	0.00129	CcSEcCtD
Terconazole—Gastrointestinal pain—Methotrexate—lung cancer	0.00122	0.00128	CcSEcCtD
Terconazole—Urticaria—Methotrexate—lung cancer	0.00119	0.00124	CcSEcCtD
Terconazole—Abdominal pain—Methotrexate—lung cancer	0.00118	0.00123	CcSEcCtD
Terconazole—Body temperature increased—Methotrexate—lung cancer	0.00118	0.00123	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00118	0.00123	CcSEcCtD
Terconazole—Pain—Doxorubicin—lung cancer	0.00111	0.00116	CcSEcCtD
Terconazole—Hypersensitivity—Methotrexate—lung cancer	0.0011	0.00115	CcSEcCtD
Terconazole—Asthenia—Methotrexate—lung cancer	0.00107	0.00112	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—lung cancer	0.00107	0.00111	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—lung cancer	0.00106	0.00111	CcSEcCtD
Terconazole—Pruritus—Methotrexate—lung cancer	0.00106	0.0011	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—lung cancer	0.00103	0.00107	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—lung cancer	0.00102	0.00107	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—lung cancer	0.00102	0.00107	CcSEcCtD
Terconazole—Dizziness—Methotrexate—lung cancer	0.000988	0.00103	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—lung cancer	0.000953	0.000996	CcSEcCtD
Terconazole—Vomiting—Methotrexate—lung cancer	0.00095	0.000992	CcSEcCtD
Terconazole—Rash—Methotrexate—lung cancer	0.000942	0.000984	CcSEcCtD
Terconazole—Dermatitis—Methotrexate—lung cancer	0.000941	0.000983	CcSEcCtD
Terconazole—Headache—Methotrexate—lung cancer	0.000936	0.000978	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—lung cancer	0.000928	0.00097	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—lung cancer	0.000915	0.000956	CcSEcCtD
Terconazole—Nausea—Methotrexate—lung cancer	0.000887	0.000927	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—lung cancer	0.000856	0.000894	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—lung cancer	0.000823	0.000859	CcSEcCtD
Terconazole—Rash—Doxorubicin—lung cancer	0.000816	0.000852	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—lung cancer	0.000815	0.000851	CcSEcCtD
Terconazole—Headache—Doxorubicin—lung cancer	0.00081	0.000847	CcSEcCtD
Terconazole—Nausea—Doxorubicin—lung cancer	0.000768	0.000803	CcSEcCtD
